Biotech's research and development focus is shifting toward specialty therapy areas. How can firms differentiate themselves as the sector evolves? Baird Capital discusses the changing market and its recent experience in the space.
Healthcare organizations are looking for clinical workflow and automation technology that translates data into action – and buyers are eager to acquire attractive assets. Baird Global Investment Banking investigates current investment drivers and buyer dynamics.